Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL107622 | 1.00 | SLC34A1 (0.42) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL5803229 | 0.94 | SLC34A1 (0.39) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL31145481 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL5790019 | 0.94 | SLC34A1 (0.39) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL5792056 | 0.94 | SLC34A1 (0.39) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL5789473 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL10746522 | 0.94 | SLC34A1 (0.46) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL22451 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL8720297 | 0.94 | SLC34A1 (0.46) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL10750036 | 0.94 | SLC34A1 (0.46) | SLC34A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100040647-A1 | VACCINE | GLAXOSMITHKLINE BIOLOGICALS S.A. (BE) | 2010-02-18 | — | — | US | claimed |
| US-20150273047-A1 | VACCINE | GLAXOSMITHKLINE BIOLOGICALS S.A. (BE) | 2015-10-01 | — | — | US | disclosed |
| US-8883166-B2 | Combination vaccines with whole cell pertussis antigen | NOVARTIS AG (CH) | 2014-11-11 | — | — | US | disclosed |
| US-20090214586-A1 | Combination Vaccines With Whole Cell Pertussis Antigen | GLAXOSMITHKLINE BIOLOGICALS SA (IT) | 2009-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100040647-A1 | VACCINE | ANTXR2, PDCD5, DPY30 | SLC34A1 4418/4885LMNA 3519/4885 |
| US-20090214586-A1 | Combination Vaccines With Whole Cell Pertussis Antigen | HLA-B, PWWP2B, CD2 | SLC34A1 1847/4885LMNA 2038/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.